Department of Biotechnology
inStem (Institute for Stem Cell Science and Regenerative Medicine)

Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala.

Publication Type

Research Support, N.I.H., Extramural

Date of Publication

January 7, 2020

Journal

Proceedings of the National Academy of Sciences of the United States of America

Volume/Issue

117/1

ISSN

1091-6490

Even a brief exposure to severe stress strengthens synaptic connectivity days later in the amygdala, a brain area implicated in the affective symptoms of stress-related psychiatric disorders. However, little is known about the synaptic signaling mechanisms during stress that eventually culminate in its delayed impact on the amygdala. Hence, we investigated early stress-induced changes in amygdalar synaptic signaling in order to prevent its delayed effects. Whole-cell recordings in basolateral amygdala (BLA) slices from rats revealed higher frequency of miniature excitatory postsynaptic currents (mEPSCs) immediately after 2-h immobilization stress. This was replicated by inhibition of cannabinoid receptors (CBR), suggesting a role for endocannabinoid (eCB) signaling. Stress also reduced -arachidonoylethanolamine (AEA), an endogenous ligand of CBR. Since stress-induced activation of fatty acid amide hydrolase (FAAH) reduces AEA, we confirmed that oral administration of an FAAH inhibitor during stress prevents the increase in synaptic excitation in the BLA soon after stress. Although stress also caused an immediate reduction in synaptic inhibition, this was not prevented by FAAH inhibition. Strikingly, FAAH inhibition during the traumatic stressor was also effective 10 d later on the delayed manifestation of synaptic strengthening in BLA neurons, preventing both enhanced mEPSC frequency and increased dendritic spine-density. Thus, oral administration of an FAAH inhibitor during a brief stress prevents the early synaptic changes that eventually build up to hyperexcitability in the amygdala. This framework is of therapeutic relevance because of growing interest in targeting eCB signaling to prevent the gradual development of emotional symptoms and underlying amygdalar dysfunction triggered by traumatic stress.

Alternate Journal

Proc Natl Acad Sci U S A

PubMed ID

31843894

PubMed Central ID

PMC6955336

Authors

Farhana Yasmin
Roberto Colangeli
Maria Morena
Sarah Filipski
Mario van der Stelt
Quentin J Pittman
Cecilia J Hillard
G Campbell Teskey
Bruce S McEwen
Matthew N Hill
Sumantra Chattarji

Keywords

Administration, Oral
Enzyme Inhibitors/administration & dosage
Amidohydrolases/antagonists & inhibitors
Excitatory Postsynaptic Potentials/drug effects
Rats
Arachidonic Acids
Excitatory Postsynaptic Potentials/physiology
Enzyme Inhibitors
Basolateral Nuclear Complex/physiology
Polyunsaturated Alkamides
Basolateral Nuclear Complex
Cannabinoid Receptor Antagonists
Animals
Receptor, Cannabinoid, CB1
Stress, Psychological
Cannabinoid Receptor Antagonists/administration & dosage
Signal Transduction
Receptor, Cannabinoid, CB1/antagonists & inhibitors
Stress, Psychological/drug therapy
Emotions
Receptor, Cannabinoid, CB1/metabolism
Stress, Psychological/psychology
Emotions/drug effects
Male
Signal Transduction/drug effects
Amidohydrolases
Emotions/physiology
Humans
Signal Transduction/physiology
Excitatory Postsynaptic Potentials
Endocannabinoids
Disease Models, Animal
Stress, Psychological/physiopathology
Amidohydrolases/metabolism
Endocannabinoids/metabolism